Get access

Including Mood in the Proposed Criteria for Refractory Migraine

Authors


  • Conflict of Interest: Dr. Schulman has served as a consultant to NuPathe and Zogenix. He is on the speakers' bureau of Merck and Impax. He has received research funding from NuPathe and has received royalties from Oxford University Press.

No abstract is available for this article.

Get access to the full text of this article

Ancillary